missing translation for 'onlineSavingsMsg'
Learn More

JAR (human choriocarcinoma) Whole cell lysate, Non-denatured, Abnova

Non-denatured whole cell lysate of JAR (human choriocarcinoma)

Brand:  Abnova L003V2.200ug

Product Code. 16049495

  • 112.00€ / 200µg
Estimated Shipment: 29-01-2025
to see stock.
Explore more special offers
Add to basket
This item is not returnable. View return policy

Description

Description

  • Tissue: Placenta
  • Host: Human
  • Lysis Buffer: Modified RIPA Lysis Buffer: 50mM Tris-HCl pH 7.4, 150mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate, 1mM PMSF
  • Storage buffer: In modified RIPA Lysis Buffer

Western Blotting, Immunoprecipitation

Specifications

Specifications

Immunoprecipitation, Western Blot
Whole cell lysate (non-denatured)
Cell lysate was prepared by homogenization in ice-cold modified RIPA Lysis Buffer with cocktail of protease inhibitors (Sigma). Cell debris was removed by centrifugation. Protein concentration was determined with Bradford assay (Bio-Rad protein assay, Microplate Standard assay).
200 μg
Human
Store at -80°C. Aliquot to avoid repeated freezing and thawing.
Placenta
Modified RIPA Lysis Buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate, 1mM PMSF.
12.5% SDS-PAGE Stained with Coomassie Blue.
In modified RIPA Lysis Buffer.
5 mg/mL
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.